Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

Human papillomavirus, vaccines and women's health: questions and cautions

Abby Lippman, Ryan Melnychuk, Carolyn Shimmin and Madeline Boscoe
CMAJ August 28, 2007 177 (5) 484-487; DOI: https://doi.org/10.1503/cmaj.070944
Abby Lippman PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan Melnychuk PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Shimmin BJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madeline Boscoe RN DU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint

    Figure 1: Avoidable mortality (age-standardized expected years of life lost per 100 000 people) due to cervical cancer in Canada from 1971 to 1996, by income quintile. Reproduced, with permission, from James et al.6 Copyright © 2007, BMJ Publishing Group Ltd.

  • Figure2
    • Download figure
    • Open in new tab
    • Download powerpoint

    Box 1.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 177 (5)
CMAJ
Vol. 177, Issue 5
28 Aug 2007
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Human papillomavirus, vaccines and women's health: questions and cautions
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Human papillomavirus, vaccines and women's health: questions and cautions
Abby Lippman, Ryan Melnychuk, Carolyn Shimmin, Madeline Boscoe
CMAJ Aug 2007, 177 (5) 484-487; DOI: 10.1503/cmaj.070944

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Human papillomavirus, vaccines and women's health: questions and cautions
Abby Lippman, Ryan Melnychuk, Carolyn Shimmin, Madeline Boscoe
CMAJ Aug 2007, 177 (5) 484-487; DOI: 10.1503/cmaj.070944
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • General questions and cautions
    • General recommendations
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • Dans ce numéro
  • Human papillomavirus vaccines launch a new era in cervical cancer prevention
  • Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection
  • Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials
  • Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women
  • Patient information about HPV and the HPV vaccine
  • PubMed
  • Google Scholar

Cited By...

  • Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study
  • Childhood Immunization: When Physicians and Parents Disagree
  • Good girls do...get vaccinated: HPV, mass marketing and moral dilemmas for sexually active young women
  • Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?
  • Human papillomavirus (HPV) vaccination and the development of public policies
  • Approuvez-vous les 300 M $ pour la vaccination contre le VPH?: NON
  • Do you approve of spending $300 million on HPV vaccination?: NO
  • Vaccination against human papillomavirus
  • Vaccination against human papillomavirus
  • Vaccination against human papillomavirus
  • Vaccination against human papillomavirus
  • Vaccination against human papillomavirus
  • Vaccination against human papillomavirus
  • Vaccination against human papillomavirus
  • Google Scholar

More in this TOC Section

  • Antiracism as a foundational competency: reimagining CanMEDS through an antiracist lens
  • Keeping the front door open: ensuring access to primary care for all in Canada
  • Improving post-tuberculosis care in Canada
Show more Commentary

Similar Articles

Collections

  • Topics
    • Drugs: immunologic
    • Sexually transmitted infections
    • Vaccination

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire